https://old.journalforclinicalstudies.com/pfizers-covid-19-antiviral-paxlovid-hits-worldwide-demand-slump-report/ 2022-04-20T12:23:10+00:00 https://old.journalforclinicalstudies.com/after-rivals-fda-rebuffs-gsk-targets-class-first-oral-approval-in-chronic-kidney-disease-anemia/ 2022-04-20T12:22:10+00:00 https://old.journalforclinicalstudies.com/pfizer-asks-hourly-staffers-to-return-overpayments-in-aftermath-of-vendors-cyberattack-reports/ 2022-04-04T13:33:10+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-trying-to-switch-patients-to-rybelsus-launches-new-tv-ad/ 2022-04-04T13:31:17+00:00 https://old.journalforclinicalstudies.com/zealand-becomes-a-lesson-in-the-rigors-of-commercialization-as-a-slow-launch-triggers-90-staff-cut-ceo-exit/ 2022-04-04T13:29:41+00:00 https://old.journalforclinicalstudies.com/gileads-kite-flies-higher-as-yescarta-leads-car-t-therapy-class-to-earlier-lymphoma-treatment/ 2022-04-04T13:27:55+00:00 https://old.journalforclinicalstudies.com/bristol-myers-ceo-caforio-takes-pay-cut-as-human-capital-metric-drags-down-bonus/ 2022-04-04T13:26:04+00:00 https://old.journalforclinicalstudies.com/viatris-after-closing-massive-west-virginia-plant-sells-it-for-1/ 2022-04-04T13:24:20+00:00 https://old.journalforclinicalstudies.com/in-major-shake-up-novartis-combines-pharma-oncology-units-leaving-cancer-commercial-head-cmo-out-of-job/ 2022-04-04T13:22:44+00:00 https://old.journalforclinicalstudies.com/getting-a-grip-on-covid-19-test-samples/ 2022-04-01T10:04:54+00:00 https://old.journalforclinicalstudies.com/2022-cold-chain-predictions-creating-a-new-normal/ 2022-04-01T10:04:19+00:00 https://old.journalforclinicalstudies.com/advanced-technologies-are-harnessing-patient-information-to-drive-better-safety/ 2022-04-01T10:03:47+00:00 https://old.journalforclinicalstudies.com/ai-ml-to-generate-medical-insights-while-maintaining-patient-data-security-and-privacy/ 2022-04-01T10:03:08+00:00 https://old.journalforclinicalstudies.com/using-machine-learning-to-identify-at-risk-sites-in-acute-schizophrenia-clinical-trials/ 2022-04-01T10:02:34+00:00 https://old.journalforclinicalstudies.com/the-biotech-revolution-the-manufacturing-quality-implications-of-cell-and-gene-therapies/ 2022-04-01T10:02:02+00:00 https://old.journalforclinicalstudies.com/optimising-early-clinical-development-strategies-in-oncology/ 2022-04-01T10:00:32+00:00 https://old.journalforclinicalstudies.com/simplifying-the-process-of-managing-complex-country-by-country-regulations-in-clinical-trials/ 2022-04-01T09:59:53+00:00 https://old.journalforclinicalstudies.com/how-a-defined-informatics-entity-is-the-key-to-bridging-pharmas-data-divide/ 2022-04-01T09:59:25+00:00 https://old.journalforclinicalstudies.com/operating-a-clinical-trial-in-the-cloud/ 2022-04-01T09:58:49+00:00 https://old.journalforclinicalstudies.com/key-clinical-trial-considerations-for-the-new-normal-and-the-future/ 2022-04-01T09:58:20+00:00 https://old.journalforclinicalstudies.com/advancing-data-from-the-real-world-novel-approaches-to-clinical-studies/ 2022-04-01T09:57:47+00:00 https://old.journalforclinicalstudies.com/cell-and-gene-start-ups-need-cdmo-2-0/ 2022-04-01T09:57:13+00:00 https://old.journalforclinicalstudies.com/bluebird-bio-has-doubts-about-continuing-to-do-business-through-2022-announces-cfo-resignation/ 2022-03-31T13:22:31+00:00 https://old.journalforclinicalstudies.com/pfizer-recalls-2nd-blood-pressure-med-in-a-week-again-on-potential-carcinogen-fears/ 2022-03-31T13:21:50+00:00 https://old.journalforclinicalstudies.com/gilead-drops-unclear-win-for-key-trodelvy-breast-cancer-trial-poking-holes-in-ceos-oncology-plan/ 2022-03-31T13:21:01+00:00 https://old.journalforclinicalstudies.com/that-key-gilead-breast-cancer-readout-try-2024-and-dont-get-your-hopes-up-analyst/ 2022-03-31T13:20:13+00:00 https://old.journalforclinicalstudies.com/take-part-in-the-pharmapack-survey/ 2022-03-31T13:19:19+00:00 https://old.journalforclinicalstudies.com/biontech-curevac-part-of-3-14b-deal-to-bolster-german-vaccine-capacity-through-2029-report/ 2022-03-31T13:18:46+00:00 https://old.journalforclinicalstudies.com/sprout-hopes-women-will-think-pink-when-it-comes-to-treating-hypoactive-sexual-desire-disorder/ 2022-03-31T10:10:36+00:00 https://old.journalforclinicalstudies.com/abbvie-eli-lilly-novartis-and-more-cut-back-in-russia-amid-corporate-exodus-over-ukraine-war/ 2022-03-31T10:08:51+00:00 https://old.journalforclinicalstudies.com/lilly-and-boehringers-jardiance-trailing-azs-farxiga-in-chronic-kidney-disease-posts-efficacy-win/ 2022-03-31T10:01:59+00:00 https://old.journalforclinicalstudies.com/biogen-piles-on-more-long-term-aduhelm-data-linking-biomarker-to-alzheimers-clinical-benefit/ 2022-03-31T10:00:59+00:00 https://old.journalforclinicalstudies.com/biotech-execs-who-pinched-genentech-trade-secrets-headed-to-prison/ 2022-03-31T10:00:08+00:00 https://old.journalforclinicalstudies.com/as-rivals-eye-unjustified-royalties-pfizer-partner-sues-to-defend-covid-19-shot-comirnaty/ 2022-03-31T09:59:21+00:00 https://old.journalforclinicalstudies.com/as-russian-invasion-persists-roche-teva-novartis-merck-and-more-make-renewed-push-to-support-besieged-ukraine/ 2022-03-31T09:58:36+00:00 https://old.journalforclinicalstudies.com/moderna-seeks-fda-nod-for-covid-vaccine-in-children-under-6-starts-delayed-filing-for-older-kids/ 2022-03-31T09:57:16+00:00 https://old.journalforclinicalstudies.com/uk-watchdog-slaps-az-allergan-gsk-sanofi-and-brittania-for-marketing-breaches/ 2022-03-31T09:56:40+00:00 https://old.journalforclinicalstudies.com/using-sumo-ads-moderna-makes-a-heavy-marketing-push-in-japan-to-rebuild-trust-in-its-covid-19-vaccine/ 2022-03-31T09:56:00+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-and-novartis-put-victoza-patent-suit-to-bed-teeing-up-sandoz-copycat-by-2024/ 2022-03-31T09:54:12+00:00 https://old.journalforclinicalstudies.com/no-small-feat-albireo-ceo-talks-biotechs-commercial-transition-amid-bylvay-launch/ 2022-03-31T09:49:33+00:00 https://old.journalforclinicalstudies.com/in-a-busy-month-pfizer-extends-recall-of-blood-pressure-meds-to-the-uk/ 2022-03-30T14:30:29+00:00 https://old.journalforclinicalstudies.com/on-a-roll-sanofi-raises-dupixents-peak-sales-target-to-e13b-plus/ 2022-03-30T14:25:46+00:00 https://old.journalforclinicalstudies.com/antares-lipocine-expand-testosterone-therapy-offerings-with-fda-nod-for-a-new-oral-med-for-hypogonadism/ 2022-03-30T14:24:01+00:00 https://old.journalforclinicalstudies.com/after-fda-green-lights-a-second-covid-booster-official-says-another-could-come-in-the-fall/ 2022-03-30T14:19:51+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-snags-high-dose-ozempic-approval-turning-up-the-heat-on-lillys-trulicity/ 2022-03-30T14:16:34+00:00 https://old.journalforclinicalstudies.com/teva-recalls-one-lot-of-leukemia-med-after-finding-particulates-in-vial/ 2022-03-30T14:14:44+00:00 https://old.journalforclinicalstudies.com/mallinckrodt-inks-260m-settlement-with-us-to-resolve-medicaid-underpayment-and-kickbacks-allegations/ 2022-03-09T15:20:12+00:00 https://old.journalforclinicalstudies.com/fresenius-nets-nba-all-star-and-transplant-recipient-sean-elliot-for-kidney-disease-campaign/ 2022-03-09T15:18:54+00:00 https://old.journalforclinicalstudies.com/pressing-for-label-change-vaccine-giant-sanofi-takes-seqirus-influenza-imbroglio-to-the-fda/ 2022-03-09T15:17:54+00:00 https://old.journalforclinicalstudies.com/alnylam-explores-the-rare-disease-journey-in-a-new-hard-hitting-documentary/ 2022-03-02T22:42:40+00:00 https://old.journalforclinicalstudies.com/novartis-sells-pair-of-manufacturing-plants-as-sandoz-strategic-review-rolls-on/ 2022-03-02T22:40:45+00:00 https://old.journalforclinicalstudies.com/merck-loses-another-vet-this-time-bidding-adieu-to-chief-patient-officer-gerberding/ 2022-03-02T22:39:04+00:00 https://old.journalforclinicalstudies.com/bms-novartis-akebia-and-more-face-fda-approval-decisions-soon-with-big-sales-on-the-line/ 2022-03-02T22:37:31+00:00 https://old.journalforclinicalstudies.com/fda-says-no-thank-you-to-xpovios-cancer-expansion-bid-prompting-karyopharm-to-run-new-study/ 2022-03-02T22:35:30+00:00 https://old.journalforclinicalstudies.com/pfizer-to-join-jj-moderna-in-shareholder-vote-showdown-on-vaccine-pricing-strategy-manufacturing-tech-sharing/ 2022-03-02T22:32:28+00:00 https://old.journalforclinicalstudies.com/after-raking-in-billions-with-its-covid-shot-moderna-faces-patent-infringement-suit-related-to-vaccine-delivery-tech/ 2022-03-02T22:29:59+00:00 https://old.journalforclinicalstudies.com/intricacies-and-future-considerations-for-the-cell-and-gene-therapy-cold-chain/ 2022-02-24T11:19:17+00:00 https://old.journalforclinicalstudies.com/the-role-of-the-falsified-medicines-directive-and-delegated-regulation-in-the-supply-chain-of-clinical-trials/ 2022-02-24T11:18:50+00:00 https://old.journalforclinicalstudies.com/querying-the-queries-an-ai-approach-to-manage-clinical-data-quality/ 2022-02-24T11:18:27+00:00 https://old.journalforclinicalstudies.com/patient-engagement-and-real-world-data-drive-innovation-in-orphan-disease-drug-development/ 2022-02-24T11:17:26+00:00 https://old.journalforclinicalstudies.com/anticipating-a-renaissance-in-neuroscience-drug-development/ 2022-02-24T11:16:54+00:00 https://old.journalforclinicalstudies.com/medical-writing-benefit-of-good-medical-writing/ 2022-02-24T11:16:29+00:00 https://old.journalforclinicalstudies.com/unlocking-the-business-benefits-of-text-mining-in-regulatory-operations/ 2022-02-24T11:15:56+00:00 https://old.journalforclinicalstudies.com/a-guide-for-establishing-and-governing-data-collection-standards/ 2022-02-24T11:15:32+00:00 https://old.journalforclinicalstudies.com/the-future-of-healthcare-ecosystems-the-real-world-impact-of-idmp/ 2022-02-24T11:15:07+00:00 https://old.journalforclinicalstudies.com/clinical-trials-somewhere-between-tradition-and-digital-modernity-a-wakeup-call/ 2022-02-24T11:14:40+00:00 https://old.journalforclinicalstudies.com/deep-brain-stimulation-could-address-suicide-risk-in-individuals-resistant-to-treatment/ 2022-02-24T11:14:15+00:00 https://old.journalforclinicalstudies.com/in-home-services-a-patient-centric-approach-to-improving-recruitment-and-retention-in-clinical-trials/ 2022-02-24T11:13:51+00:00 https://old.journalforclinicalstudies.com/integrated-cdmo-growth-will-lead-to-patients-seeing-record-number-of-drugs-making-it-to-market/ 2022-02-24T11:13:25+00:00 https://old.journalforclinicalstudies.com/interview-with-clinerion-health-outcomes-in-clinical-trials/ 2022-02-24T11:12:57+00:00 https://old.journalforclinicalstudies.com/march-in-campaign-on-pfizers-prostate-cancer-med-xtandi-gets-congressional-backing-will-it-matter/ 2022-02-23T13:41:49+00:00 https://old.journalforclinicalstudies.com/astrazeneca-ceo-snared-more-than-18m-last-year-as-his-company-worked-through-highs-and-lows-of-vaccine-launch/ 2022-02-23T13:37:14+00:00 https://old.journalforclinicalstudies.com/oncologists-on-board-for-novartis-prostate-cancer-radiotherapy-but-logistics-could-hit-uptake-survey/ 2022-02-23T13:35:18+00:00 https://old.journalforclinicalstudies.com/glaxosmithkline-unveils-haleon-the-new-brand-name-for-its-outgoing-consumer-health-unit/ 2022-02-23T13:34:06+00:00 https://old.journalforclinicalstudies.com/argenxs-vyvgart-launch-finds-quick-neurologist-support-over-astrazenecas-well-entrenched-soliris-for-myasthenia-gravis/ 2022-02-23T13:33:04+00:00 https://old.journalforclinicalstudies.com/womens-telehealth-startup-alloy-turns-up-the-heat-on-men-to-bring-attention-to-menopause-symptoms/ 2022-02-23T13:31:23+00:00 https://old.journalforclinicalstudies.com/recipharm-working-on-modernas-covid-vaccine-boosts-biologics-presence-with-arranta-bio-vibalogics-buyouts/ 2022-02-23T13:30:15+00:00 https://old.journalforclinicalstudies.com/elanco-completes-sale-of-a-pair-of-plants-to-cdmo-trirx-in-kansas-and-uk/ 2022-02-15T16:05:52+00:00 https://old.journalforclinicalstudies.com/skyepharma-inks-deal-to-build-largest-microbiome-facility-in-france/ 2022-02-15T16:04:56+00:00 https://old.journalforclinicalstudies.com/eli-lilly-promises-40-discount-for-innovents-pd-1-in-last-ditch-bid-to-shift-fda-review-to-drug-pricing/ 2022-02-15T16:03:23+00:00 https://old.journalforclinicalstudies.com/nih-backed-nasal-nonaddictive-pain-prospect-clears-early-test/ 2022-02-15T16:01:33+00:00 https://old.journalforclinicalstudies.com/merck-eisais-lenvima-fails-to-improve-on-keytruda-in-bladder-cancer-as-key-padcev-readout-nears/ 2022-02-15T16:00:42+00:00 https://old.journalforclinicalstudies.com/asco-gu-jj-plays-up-precision-therapy-approach-for-zejulas-prostate-cancer-bid-after-mixed-results/ 2022-02-15T15:58:49+00:00 https://old.journalforclinicalstudies.com/pfizer-and-lillys-jak-inhibitor-safety-concerns-prompt-europe-to-scrutinize-drug-class/ 2022-02-15T15:57:11+00:00 https://old.journalforclinicalstudies.com/takeda-taps-a-doctor-turned-patient-and-spread-the-word-artist-for-rare-disease-awareness-campaign/ 2022-02-09T15:02:16+00:00 https://old.journalforclinicalstudies.com/bayer-poaches-glaxosmithkline-exec-to-lead-expanding-oncology-business-including-a-blockbuster-hopeful/ 2022-02-09T15:00:52+00:00 https://old.journalforclinicalstudies.com/jj-plowing-ahead-with-talc-bankruptcy-strategy-faces-investor-push-to-pull-product-worldwide/ 2022-02-09T14:59:42+00:00 https://old.journalforclinicalstudies.com/amgens-covid-19-manufacturing-deal-with-lilly-helped-compensate-for-lagging-aimovig-enbrel-in-q4/ 2022-02-09T14:58:04+00:00 https://old.journalforclinicalstudies.com/novo-nordisks-wegovy-passes-nice-checkpoint-on-course-to-blockbusterland/ 2022-02-09T14:57:08+00:00 https://old.journalforclinicalstudies.com/how-united-cargo-is-connecting-lifesaving-pharma-to-patients-across-the-globe/ 2022-02-09T14:55:51+00:00 https://old.journalforclinicalstudies.com/as-pfizer-reaps-megablockbuster-covid-19-sales-ceo-doesnt-see-virus-going-away-for-foreseeable-future/ 2022-02-09T14:55:05+00:00 https://old.journalforclinicalstudies.com/teva-survey-finds-covid-has-widened-the-chasm-on-health-disparities/ 2022-02-02T13:55:42+00:00 https://old.journalforclinicalstudies.com/novavax-finally-submits-its-covid-19-vaccine-to-the-fda-is-it-too-late/ 2022-02-02T13:54:23+00:00 https://old.journalforclinicalstudies.com/cms-biogen-decision-could-spell-problems-for-lilly-roche-alzheimers-drugs-half-of-surveyed-neurologists-say/ 2022-02-02T13:51:28+00:00 https://old.journalforclinicalstudies.com/glaxosmithklines-hiv-drug-cabenuva-scores-fda-nod-for-2-month-dosing/ 2022-02-02T13:49:54+00:00 https://old.journalforclinicalstudies.com/novartis-sandoz-reportedly-the-target-of-25b-buyout-bid-from-carlyle-and-blackstone/ 2022-02-02T13:46:19+00:00 https://old.journalforclinicalstudies.com/biogens-aduhelm-call-to-action-backfires-as-cms-receives-many-more-comments-in-favor-of-restrictive-coverage-analyst/ 2022-02-02T13:44:25+00:00 https://old.journalforclinicalstudies.com/novartis-amgen-settle-their-dueling-lawsuits-over-migraine-drug-aimovig/ 2022-02-02T13:42:16+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-ceo-consumer-health-split-wont-interfere-with-our-more-aggressive-approach-to-ma/ 2022-01-26T10:33:37+00:00 https://old.journalforclinicalstudies.com/samsung-biologics-outlines-mrna-ambitions-as-super-plant-speeds-toward-completion/ 2022-01-26T10:31:00+00:00 https://old.journalforclinicalstudies.com/roches-aim-to-widen-evrysdis-label-nabs-speedy-fda-review-in-young-spinal-muscular-atrophy-patients/ 2022-01-26T10:27:19+00:00 https://old.journalforclinicalstudies.com/argenx-already-deep-into-its-vyvgart-launch-charts-course-to-become-immunology-powerhouse-ceo/ 2022-01-26T10:25:28+00:00 https://old.journalforclinicalstudies.com/fda-chides-eli-lilly-for-second-misleading-ad-in-2-months-this-time-for-diabetes-blockbuster-trulicity/ 2022-01-26T10:23:36+00:00 https://old.journalforclinicalstudies.com/deciphera-details-stomach-cancer-flop-against-pfizers-sutent-cracking-the-door-open-for-off-label-use/ 2022-01-26T10:18:25+00:00 https://old.journalforclinicalstudies.com/bayer-leads-80m-funding-round-for-cellino-betting-on-new-cell-therapy-manufacturing-platform/ 2022-01-26T10:02:16+00:00 https://old.journalforclinicalstudies.com/dna-vaccine-spurs-antibodies-against-a-common-parkinsons-target-in-mice/ 2022-01-18T14:48:14+00:00 https://old.journalforclinicalstudies.com/verana-health-lands-jj-novo-backing-in-150m-round-to-fund-real-world-database-for-drug-device-development/ 2022-01-18T14:41:19+00:00 https://old.journalforclinicalstudies.com/us-faces-critical-moment-in-pricing-reform-that-wont-come-again-nonprofit-founder-says-after-tallying-554-new-hikes/ 2022-01-18T14:35:19+00:00 https://old.journalforclinicalstudies.com/with-voxzogo-approvals-adding-up-biomarin-is-underway-with-its-biggest-launch-ceo-says/ 2022-01-18T14:21:55+00:00 https://old.journalforclinicalstudies.com/emergent-biosolutions-founder-el-hibri-bids-adieu-after-cdmos-turbulent-2021/ 2022-01-18T14:05:06+00:00 https://old.journalforclinicalstudies.com/pfizers-cibinqo-snags-fda-approval-to-challenge-sanofi-and-regenerons-dupixent-in-eczema/ 2022-01-18T14:03:08+00:00 https://old.journalforclinicalstudies.com/daiichi-sankyo-with-tighter-focus-on-oncology-sells-8-aging-us-cardiovascular-drugs-to-diversifying-cosette/ 2022-01-18T13:53:17+00:00 https://old.journalforclinicalstudies.com/jpm-2022-pfizer-bumps-paxlovid-production-estimate-to-120m-for-this-year-while-also-looking-to-add-more-capacity/ 2022-01-11T11:49:23+00:00 https://old.journalforclinicalstudies.com/merck-putting-150m-on-the-table-doubles-down-on-pledge-to-tackle-maternal-mortality-and-health-inequities/ 2022-01-11T11:42:25+00:00 https://old.journalforclinicalstudies.com/catalents-fda-write-up-spurred-novo-nordisks-wegovy-supply-woes/ 2022-01-11T11:40:24+00:00 https://old.journalforclinicalstudies.com/idorsia-scores-fda-go-ahead-for-insomnia-drug-quviviq-to-rival-mercks-belsomra-eisais-dayvigo/ 2022-01-11T11:38:48+00:00 https://old.journalforclinicalstudies.com/eyeing-its-post-humira-future-abbvie-angles-for-broader-rinvoq-use-in-u-s-europe/ 2022-01-11T11:34:56+00:00 https://old.journalforclinicalstudies.com/antares-pharma-develops-novel-auto-injector-devices-for-innovative-combination-products/ 2022-01-11T11:30:15+00:00 https://old.journalforclinicalstudies.com/jpm-2022-vertexs-trikafta-holds-the-line-as-company-lays-groundwork-for-gene-editing-launch/ 2022-01-11T11:28:58+00:00 https://old.journalforclinicalstudies.com/ash-astellas-looks-for-silver-linings-in-failed-xospata-combo-trial/ 2021-12-15T11:28:55+00:00 https://old.journalforclinicalstudies.com/bayer-targets-100-green-packaging-for-consumer-health-brands-by-2030-as-part-of-e100-million-sustainability-plan/ 2021-12-15T11:25:53+00:00 https://old.journalforclinicalstudies.com/ash-roches-polivy-set-to-unlock-2b-market-in-newly-diagnosed-lymphoma-with-practice-changing-data/ 2021-12-15T11:06:47+00:00 https://old.journalforclinicalstudies.com/ash-novartis-thinks-it-knows-why-kymriah-failed-in-earlier-lymphoma-but-shifts-focus-to-next-gen-car-t-meds/ 2021-12-15T10:57:19+00:00 https://old.journalforclinicalstudies.com/csl-to-buy-vifor-for-11-7b-in-biopharmas-largest-ma-deal-this-year/ 2021-12-15T10:54:41+00:00 https://old.journalforclinicalstudies.com/cansino-taps-aerogen-for-development-commercial-supply-of-inhaled-covid-19-vaccine-hopeful/ 2021-12-15T10:52:36+00:00 https://old.journalforclinicalstudies.com/astrazeneca-and-other-lung-cancer-specialists-join-together-to-emphasize-early-screenings/ 2021-12-15T10:52:08+00:00 https://old.journalforclinicalstudies.com/shkrelis-former-company-vyera-settles-for-40m-in-antitrust-case-but-pharma-bro-still-faces-his-own-trials/ 2021-12-13T12:22:25+00:00 https://old.journalforclinicalstudies.com/for-pharmas-dealing-with-hcps-the-future-is-digital-first-and-sales-reps-2nd/ 2021-12-13T12:19:27+00:00 https://old.journalforclinicalstudies.com/pfizer-ex-employee-reach-a-deal-in-covid-19-vaccine-trade-secrets-case/ 2021-12-13T12:12:01+00:00 https://old.journalforclinicalstudies.com/teligent-edge-pharma-yank-meds-on-superpotency-sterility-concerns/ 2021-12-13T12:07:41+00:00 https://old.journalforclinicalstudies.com/as-end-of-new-york-opioid-trial-nears-abbvies-allergan-ponies-up-200m-to-settle-its-part-of-the-case/ 2021-12-13T11:50:16+00:00 https://old.journalforclinicalstudies.com/amid-consumer-spinoff-and-ceo-transition-johnson-johnson-names-new-leadership-team/ 2021-12-13T11:46:11+00:00 https://old.journalforclinicalstudies.com/amid-aduhelms-rocky-launch-biogen-eyes-large-scale-layoffs/ 2021-12-13T11:43:30+00:00 https://old.journalforclinicalstudies.com/another-samsung-bioepis-biocon-viatris-mull-merging-biosimilar-businesses/ 2021-12-13T11:30:59+00:00 https://old.journalforclinicalstudies.com/klick-health-spreads-good-cheer-and-100-bills-in-annual-holiday-video-highlighting-the-joy-of-giving/ 2021-12-13T11:28:57+00:00 https://old.journalforclinicalstudies.com/novartis-ceo-narashimhan-confirms-interest-in-purchase-of-generics-unit-sandoz/ 2021-12-13T11:26:38+00:00 https://old.journalforclinicalstudies.com/chinas-new-nrdl-biocon-viatris-biosimilar-merger-avistones-200m-series-a/ 2021-12-13T11:23:51+00:00 https://old.journalforclinicalstudies.com/glaxosmithkline-vet-departs-for-vifor-the-rumored-target-of-a-7-1b-csl-buyout/ 2021-12-13T11:15:40+00:00 https://old.journalforclinicalstudies.com/merck-eisais-007-goes-down-as-keytruda-lenvima-combo-fails-in-newly-diagnosed-lung-cancer/ 2021-12-13T11:12:11+00:00 https://old.journalforclinicalstudies.com/lawmakers-blast-pharma-for-outrageous-prices-and-anticompetitive-conduct-in-culmination-of-3-year-probe/ 2021-12-13T10:42:42+00:00 https://old.journalforclinicalstudies.com/after-its-7-6b-buyout-fell-through-sobi-scores-nice-backing-for-rare-disease-drug-aspaveli/ 2021-12-10T12:05:30+00:00 https://old.journalforclinicalstudies.com/jj-celebrates-nurses-with-a-new-campaign-in-wake-of-burnout-plaguing-the-profession/ 2021-12-10T12:03:15+00:00 https://old.journalforclinicalstudies.com/astrazenecas-evusheld-becomes-first-fda-authorized-covid-antibody-to-protect-the-immunocompromised-before-exposure/ 2021-12-10T12:01:08+00:00 https://old.journalforclinicalstudies.com/pfizer-biontech-say-omicron-partially-evades-its-covid-vaccine-but-booster-can-restore-protection/ 2021-12-10T11:59:18+00:00 https://old.journalforclinicalstudies.com/bd-seals-the-deal-to-acquire-uk-based-surgical-sealant-maker-tissuemed/ 2021-12-10T11:56:44+00:00 https://old.journalforclinicalstudies.com/ash-senti-bios-gene-circuit-car-nk-cell-therapy-enhances-cancer-killing-and-safety-in-leukemia-models/ 2021-12-10T11:54:08+00:00 https://old.journalforclinicalstudies.com/totus-tots-up-40m-in-series-a-funding-to-go-after-competitive-cancer-space/ 2021-12-10T11:51:31+00:00 https://old.journalforclinicalstudies.com/plain-language-summaries-of-publications-what-has-covid-19-taught-us/ 2021-12-09T13:47:50+00:00 https://old.journalforclinicalstudies.com/emerging-field-has-fast-become-a-vital-component-in-the-medical-discovery-process/ 2021-12-09T13:45:19+00:00 https://old.journalforclinicalstudies.com/the-journey-from-hesitancy-to-a-reliance-on-real-world-data/ 2021-12-09T13:36:53+00:00 https://old.journalforclinicalstudies.com/modernising-study-management-for-greater-visibility-and-speed-in-trials/ 2021-12-09T13:26:22+00:00 https://old.journalforclinicalstudies.com/considerations-for-clinical-trial-design-involving-radiotherapy/ 2021-12-09T13:16:59+00:00 https://old.journalforclinicalstudies.com/clinical-evaluation-of-ayurvedic-interventions-current-scenario-in-indian-market/ 2021-12-09T13:10:59+00:00 https://old.journalforclinicalstudies.com/finding-the-right-patients-for-primary-care-clinical-studies/ 2021-12-09T11:58:24+00:00 https://old.journalforclinicalstudies.com/overview-pharmacovigilance-and-risk-management/ 2021-12-09T11:54:41+00:00 https://old.journalforclinicalstudies.com/operationalising-decentralised-clinical-trials-dcts/ 2021-12-09T11:48:36+00:00 https://old.journalforclinicalstudies.com/clinical-quality-management-system-cqms-a-framework-for-operational-excellence-and-compliance-with-good-clinical-practice-gcp/ 2021-12-09T11:46:06+00:00 https://old.journalforclinicalstudies.com/what-is-cognitive-debriefing/ 2021-12-09T11:27:38+00:00 https://old.journalforclinicalstudies.com/scientific-and-ethical-issues-surrounding-the-enrolment-of-pregnant-people-in-clinical-trials/ 2021-12-09T11:23:15+00:00 https://old.journalforclinicalstudies.com/glaxosmithkline-and-virs-sotrovimab-stands-up-to-omicron-despite-other-covid-antibodies-falling-short/ 2021-12-08T16:59:52+00:00 https://old.journalforclinicalstudies.com/abbvies-rinvoq-pfizers-xeljanz-and-lillys-olumiant-slapped-with-new-fda-warnings-amid-jak-safety-crackdown/ 2021-12-08T16:56:09+00:00 https://old.journalforclinicalstudies.com/abbvies-rinvoq-notches-crohns-disease-win-amid-classwide-jak-safety-concerns/ 2021-12-08T16:53:42+00:00 https://old.journalforclinicalstudies.com/mercks-hilleman-laboratories-tees-up-58m-investment-at-new-singapore-vaccine-hub/ 2021-12-08T16:51:20+00:00 https://old.journalforclinicalstudies.com/former-pharma-ceo-plundered-millions-from-his-own-company-doj-says/ 2021-12-08T16:34:12+00:00 https://old.journalforclinicalstudies.com/alvotech-battling-abbvie-over-its-humira-biosim-raises-450m-and-tees-up-nasdaq-debut/ 2021-12-08T16:31:37+00:00 https://old.journalforclinicalstudies.com/watch-out-pfizer-and-alnylam-astrazeneca-wades-deeper-into-rare-diseases-with-ionis-tie-up/ 2021-12-08T16:27:27+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-sanofi-and-eli-lilly-cut-insulin-prices-and-lose-share-in-chinas-latest-cost-squeeze/ 2021-12-01T17:46:04+00:00 https://old.journalforclinicalstudies.com/pfizer-boosts-paxlovid-manufacturing-capacity-as-mercks-rival-covid-pill-hits-surprise-efficacy-setback/ 2021-12-01T17:41:24+00:00 https://old.journalforclinicalstudies.com/amgen-asks-supreme-court-to-take-up-its-high-profile-pcsk9-patent-case-against-sanofi-and-regeneron/ 2021-12-01T17:38:00+00:00 https://old.journalforclinicalstudies.com/moderna-regeneron-warn-about-the-effectiveness-of-covid-19-drugs-vaccines-against-the-omicron-variant/ 2021-12-01T17:33:54+00:00 https://old.journalforclinicalstudies.com/aspen-closes-in-on-africa-license-for-johnson-johnsons-covid-19-vaccine/ 2021-12-01T17:29:31+00:00 https://old.journalforclinicalstudies.com/gsks-viiv-looks-to-future-of-injectable-hiv-treatment-as-long-acting-prep-decision-looms/ 2021-12-01T15:28:33+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibbs-next-gen-autoimmune-med-starts-high-stakes-fda-review-amid-classwide-jak-scrutiny/ 2021-12-01T15:21:16+00:00 https://old.journalforclinicalstudies.com/media-information-2021/ 2021-11-29T16:11:20+00:00 https://old.journalforclinicalstudies.com/amgens-otezla-repatha-and-biosimilars-put-on-notice-with-challenging-years-ahead/ 2021-11-24T10:23:37+00:00 https://old.journalforclinicalstudies.com/sagent-pharmaceuticals-recalls-injectable-seizure-med-thanks-to-familiar-packaging-glitch/ 2021-11-24T10:18:41+00:00 https://old.journalforclinicalstudies.com/novartis-may-have-a-buyer-for-21b-generics-unit-sandoz/ 2021-11-24T10:13:45+00:00 https://old.journalforclinicalstudies.com/astrazeneca-ceo-questions-mrna-vaccine-superiority-raising-theory-that-his-companys-shot-offers-longer-lasting-protection/ 2021-11-24T10:08:27+00:00 https://old.journalforclinicalstudies.com/aria-side-effects-surface-in-40-of-patients-on-biogens-alzheimers-drug-aduhelm/ 2021-11-24T10:04:20+00:00 https://old.journalforclinicalstudies.com/pfizer-to-become-100b-behemoth-next-year-thanks-to-covid-19-drug-and-vaccine/ 2021-11-24T10:00:35+00:00 https://old.journalforclinicalstudies.com/clinerion-patient-network-explorer-technology-used-by-the-swiss-personalized-health-network-sphn-to-enable-feasibility-queries-on-clinical-data-across-all-five-of-switzerlands-university-hospitals/ 2021-11-22T09:37:40+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2021/11/Logo_CLINERION.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2021/11/SPHN-Logo-Square.png https://old.journalforclinicalstudies.com/wp-content/uploads/2021/11/SPHN_FQS.jpg https://old.journalforclinicalstudies.com/eli-lilly-and-boehringer-ingelheims-jardiance-stays-on-its-heart-failure-winning-streak%e2%81%a0-this-time-in-acute-patients/ 2021-11-17T10:13:52+00:00 https://old.journalforclinicalstudies.com/jjs-invokana-chases-azs-farxiga-and-lillys-jardiance-with-phase-3-heart-failure-win/ 2021-11-17T10:10:20+00:00 https://old.journalforclinicalstudies.com/pharma-backed-destination-healthy-skin-rv-nears-end-of-2021-road-tour/ 2021-11-17T10:06:39+00:00 https://old.journalforclinicalstudies.com/pfizer-like-merck-inks-deal-to-license-covid-19-pill-and-boost-global-supply/ 2021-11-17T10:03:42+00:00 https://old.journalforclinicalstudies.com/abbvies-unsupported-price-hikes-on-humira-drove-1-4b-in-extra-u-s-drug-spending-icer-says/ 2021-11-17T09:38:25+00:00 https://old.journalforclinicalstudies.com/viatris-launched-two-versions-of-its-interchangeable-insulin-biosimilar-why/ 2021-11-17T09:32:24+00:00 https://old.journalforclinicalstudies.com/buffetts-berkshire-exited-merck-investment-just-before-covid-pill-boost-further-trimmed-abbvie-and-bms-holdings/ 2021-11-17T09:23:29+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibbs-opdivo-posts-another-win-in-early-lung-cancer-but-debate-over-treatment-approach-likely-remains/ 2021-11-10T11:44:56+00:00 https://old.journalforclinicalstudies.com/lilly-and-boehringers-jardiance-shows-benefits-for-those-with-intimately-linked-heart-failure-and-kidney-disease/ 2021-11-10T11:41:07+00:00 https://old.journalforclinicalstudies.com/with-mercks-oral-covid-19-med-molnupiravir-set-for-authorization-u-s-spends-another-1b-for-1-4-million-courses/ 2021-11-10T11:39:57+00:00 https://old.journalforclinicalstudies.com/biohaven-taps-pfizer-for-global-nurtec-push-in-deal-worth-up-to-1-24b/ 2021-11-10T11:39:14+00:00 https://old.journalforclinicalstudies.com/as-biontech-raises-expected-covid-19-vaccine-sales-to-19-6b-ceo-stumps-for-wider-booster-use/ 2021-11-10T11:38:46+00:00 https://old.journalforclinicalstudies.com/biogens-aduhelm-records-one-patient-death-is-the-controversial-alzheimers-drug-to-blame/ 2021-11-10T11:38:21+00:00 https://old.journalforclinicalstudies.com/sgs-increases-biosafety-testing-capacity-at-its-glasgow-facility/ 2021-11-08T15:45:02+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2021/10/SGS-Glasgow-Facility-Expansion.png https://old.journalforclinicalstudies.com/sgs-opens-new-state-of-the-art-site-for-clinical-research-in-antwerp-belgium/ 2021-11-08T15:43:38+00:00 https://old.journalforclinicalstudies.com/novartis-looks-for-silver-lining-in-2b-canakinumab-repurposing-after-2nd-lung-cancer-failure/ 2021-11-08T15:42:43+00:00 https://old.journalforclinicalstudies.com/what-would-medicare-price-negotiations-bring-to-the-us-look-to-europe-lilly-ceo-ricks-says/ 2021-11-08T15:41:31+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibb-after-passing-on-acceleron-now-eyes-aurinia-takeout-bloomberg/ 2021-11-08T15:40:05+00:00 https://old.journalforclinicalstudies.com/oncopeptides-shares-crash-as-it-pulls-pepaxto-from-the-market-plans-to-shut-down-commercial-units/ 2021-11-08T15:39:02+00:00